Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Watch List: Amicus Therapeutics (NASDAQ:FOLD), AVEO Pharmaceuticals (NASDAQ:AVEO), Yahoo! Inc. (NASDAQ:YHOO), Anika Therapeutics Inc. (NASDAQ:ANIK), China Lodging Group, Limited (NASDAQ:HTHT) - Property Mentor Group

Watch List: Amicus Therapeutics (NASDAQ:FOLD), AVEO Pharmaceuticals (NASDAQ:AVEO), Yahoo! Inc. (NASDAQ:YHOO), Anika Therapeutics Inc. (NASDAQ:ANIK), China Lodging Group, Limited (NASDAQ:HTHT)


On Thursday shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) closed at $12.46. Company’s sales growth for last 5 years was -54.90%. Amicus Therapeutics Inc. (NASDAQ:FOLD) plans to file for accelerated approval of its experimental treatment for a rare, inherited disease following meetings with regulators in the U.S. and Europe. In the U.S., the company plans to file for approval of the drug, called migalastat, with the Food and Drug Administration in the second half of the year, while it plans on asking for approval in Europe during the second quarter.

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) in last trading activity increased 11.85% to close at $1.51. Company weekly performance is 5.59% while its quarterly performance stands at 112.68%. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is -25.25% away from its 52 week high. RBC Capital upgraded shares of AVEO Pharmaceuticals Inc (NASDAQ:AVEO) from an underperform rating to a sector perform rating in a research note released on Monday morning,TheFlyOnTheWall.com reports. They currently have $3.00 target price on the stock, up from their previous target price of $2.00.

On Thursday shares of Yahoo! Inc. (NASDAQ:YHOO) closed at $44.98. Company’s sales growth for last 5 years was -6.50% and EPS growth for next 5 years is recorded as -10.55%. Yahoo Inc. (NASDAQ:YHOO) is shutting down its office in China, a move that will eliminate 200 to 300 jobs, according to a person with knowledge of the matter. The company, which has been consolidating offices and trimming staff around the world, told employees in Beijing that it will close the site, Yahoo said Wednesday

Anika Therapeutics Inc. (NASDAQ:ANIK) has 2.50% insider ownership while its institutional ownership stands at 81.00%. In last trading activity company’s stock closed at $41.47. Anika Therapeutics Inc. (Nasdaq:ANIK) announced that its President and Chief Executive Officer Charles H. Sherwood Ph.D. will be presenting at the 10th Annual Canaccord Genuity Musculoskeletal Conference on Tuesday March 24 2015 at 12:30 p.m. ET/ 9:30 a.m. PT. The conference is being held at the MGM Grand Hotel in Las Vegas Nevada.

On last trading day China Lodging Group, Limited (NASDAQ:HTHT) decreased -2.46% to close at $17.47. Its volatility for the week is 2.56% while volatility for the month is 3.32%. HTHT’s sales growth for past 5 years was 40.40% and its EPS growth for past 5 years was 19.60%. China Lodging Group, Limited (NASDAQ:HTHT) monthly performance is -21.02%.On March 10, China Lodging Group Limited (NASDAQ:HTHT) reported Q4 EPS of $0.12, $0.04 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $208.9 million versus the consensus estimate of $208.8 million.


Leave a Reply

Your email address will not be published. Required fields are marked *